Filing Details
- Accession Number:
- 0001209191-21-042291
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-21 20:00:50
- Reporting Period:
- 2021-06-17
- Accepted Time:
- 2021-06-21 20:00:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1478320 | Adaptive Biotechnologies Corp | ADPT | Biological Products, (No Disgnostic Substances) (2836) | 270907024 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1799081 | L Stacy Taylor | C/O Adaptive Biotechnologies 1551 Eastlake Ave E Ste 200 Seattle WA 98102 | Svp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-17 | 1,041 | $7.80 | 16,077 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-06-17 | 1,771 | $6.55 | 17,848 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-06-17 | 1,354 | $31.71 | 19,202 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-17 | 4,166 | $40.00 | 15,036 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-06-17 | 1,041 | $0.00 | 1,041 | $7.80 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-06-17 | 1,771 | $0.00 | 1,771 | $6.55 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-06-17 | 1,354 | $0.00 | 1,354 | $31.71 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 23,959 | 2029-04-23 | No | 4 | M | Direct | |
| 17,709 | 2028-04-24 | No | 4 | M | Direct | |
| 44,688 | 2030-02-13 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020.
- The options vested with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
- The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
- The options vested with respect to 1/4 of such shares on February 13, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
Billionaire Hedge Funds
